TORONTO, ON / ACCESSWIRE / April 22, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a...
Strategic actions announced today eliminate low-margin, distributed products EAGAN, MN / ACCESSWIRE / April 22, 2021 / Dynatronics Corporation (NASDAQ:DYNT),...
In terms of production, over 50% of small molecule active pharmaceutical ingredient (API) is outsourced. DUBAI, UAE / ACCESSWIRE /...
LAS VEGAS, NV / ACCESSWIRE / April 22, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a...
LAS VEGAS, NV / ACCESSWIRE / April 22, 2021 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQB:PLNHF) ("Planet 13" or the "Company"),...
Company Ranked #57 Moving Up 230 Spots From Last YearKANSAS CITY, Mo., April 22, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation...
Glen Rock, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader...
NEW YORK, April 22, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice”), an animal health and wellness...
SHANGHAI, China, April 22, 2021 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated...
Novel glaucoma drug ready for next development phase - GLP toxicology study – on critical path to first human clinical...
Fireside Chat Being Held on Tuesday, May 4th @ 10am Eastern TimeJUPITER, Fla., April 22, 2021 (GLOBE NEWSWIRE) -- Dyadic...
MOUNTAIN VIEW, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's first quarter...
WARSAW, Ind., April 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on...
LAWRENCEVILLE, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and...
Phase 3 Study on Track to Initiate in Second Half 2021NOVATO, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical...
CALGARY, Alberta, April 22, 2021 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“Maple Leaf” or the “Company”) (NEO: MGW,...
Growth of 14% for new U.S. TYMLOS® patients in Q1, 2021 vs. Q4, 2020Q1, 2021 TYMLOS net revenue impacted by...
OAKLAND, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Disability leaves for musculoskeletal conditions such as back pain and arthritis are...
LGS is one of the most challenging developmental and epileptic encephalopathies to manage because of high seizure frequency and significant...
PHILADELPHIA and OXFORDSHIRE, United Kingdom, April 22, 2021 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy...